An interaction between warfarin and cannabidiol, a case report

por Grayson, Leslie, Vines, Brannon, Nichol, Kate, Szaflarski, Jerzy P.
Publicado 2017

Final analysis of potential drug–drug interactions between highly purified cannabidiol and anti‐seizure medications in an open‐label expanded access program

por Gaston, Tyler E., Bebin, E. Martina, Cutter, Gary R., Grayson, Leslie, Szaflarski, Jerzy P.
Publicado 2023

A preliminary study of the effects of cannabidiol (CBD) on brain structure in patients with epilepsy

por Sharma, Ayushe A., Nenert, Rodolphe, Allendorfer, Jane B., Gaston, Tyler E., Grayson, Leslie P., Hernando, Kathleen, Szaflarski, Jerzy P.
Publicado 2019

Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment‐Resistant Epilepsy

por Davis, Brittney H., Beasley, T. Mark, Amaral, Michelle, Szaflarski, Jerzy P., Gaston, Tyler, Perry Grayson, Leslie, Standaert, David G, Bebin, E. Martina, Limdi, Nita A.
Publicado 2021

White matter and neurite morphology differ in psychogenic nonepileptic seizures

por Goodman, Adam M., Allendorfer, Jane B., Blum, Andrew S., Bolding, Mark S., Correia, Stephen, Ver Hoef, Lawrence W., Gaston, Tyler E., Grayson, Leslie E., Kraguljac, Nina V., Lahti, Adrienne C., Martin, Amber N., Monroe, William S., Philip, Noah S., Tocco, Krista, Vogel, Valerie, LaFrance, W. Curt, Szaflarski, Jerzy P.
Publicado 2020